Sanofi Consumer Healthcare India Share Price Today (SANOFICONR)
TODAY IN ONE LINE
SANOFICONR edged up 0.5% on above-average volume (3.8x avg), in line with Nifty's -0.0% move, supported by recent strong earnings.
With a market cap of ₹10,847.42 Cr., it trades at a P/E of 42.04. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Sanofi Consumer Healthcare India flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 35.7% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 32.8% and Profit up 35.6%
- ●High Capital EfficiencyROCE of 89.9% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 71.6%
- ●Healthy Operating MarginsOPM is structurally strong at 35.7%
- ●High Promoter HoldingPromoters hold 71.3% skin-in-the-game
- ●Steady Dividend YieldReliable 2.88% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Sanofi Consumer Healthcare India News
What changed recently?
Recent events, corporate actions, and announcements.
Sanofi Consumer Healthcare India Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Sanofi Consumer Healthcare India Limited, framed against the sector median so the premium or discount is obvious at a glance.
Sanofi Consumer Healthcare India Limited trades at a P/E of 42.04× and P/B of 28.24×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Sanofi Consumer Healthcare India Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Sanofi Consumer Healthcare India Limited — derived from the live tape, not yesterday's close.
Sanofi Consumer Healthcare India Limited last traded at ₹4,707.2 with an intraday range of ₹4,652.1–₹4,789.3 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹4707.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 5054.70 | +347.50 | +7.38% |
| R3 | 4917.50 | +210.30 | +4.47% |
| R2 | 4853.40 | +146.20 | +3.11% |
| R1 | 4780.30 | +73.10 | +1.55% |
| PIVOT | 4716.20 | 9.00 | 0.19% |
| CURRENT | 4707.20 | — | — |
| S1 | 4643.10 | -64.10 | -1.36% |
| S2 | 4579.00 | -128.20 | -2.72% |
| S3 | 4505.90 | -201.30 | -4.28% |
| S4 | 4368.70 | -338.50 | -7.19% |
SANOFICONR is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹4652.1–₹4732.1
Trading Inside opening range
Sanofi Consumer Healthcare India Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Sanofi Consumer Healthcare India Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Sanofi Consumer Healthcare India Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹10,847.42 Cr. and reported EPS of ₹112.12.
Sanofi Consumer Healthcare India segment analysis : revenue and profit mix.
Disclosed business segments at Sanofi Consumer Healthcare India with their share of revenue and profit, switchable between consolidated and standalone reporting.
Sanofi Consumer Healthcare India discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Sanofi Consumer Healthcare India Limited.
Our AI distills the core fundamental drivers supporting Sanofi Consumer Healthcare India Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Sanofi Consumer Healthcare India Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 35.6% YoY with revenue up 32.8% YoY.
TTM EPS grew 35.7% YoY, demonstrating robust earnings acceleration momentum.
Exceptional ROCE 89.90% and operating margin 35.70% far exceed sector peers.
Low debt-to-equity 0.0006x with negligible total debt ensures financial flexibility.
Promoter holding 71.27% signals strong founder commitment and long-term alignment.
Key Risks.
P/E ratio 41.90x significantly exceeds peer median 28.9x, indicating premium valuation.
Price-to-book 27.03x far above peer median 5.2x suggests overvaluation risk.
Payout ratio 115.90% exceeds 100%, potentially straining future dividend sustainability.
Stock price flat over 52 weeks with zero momentum across all timeframes.
Company incorporated only in 2023 with limited historical data for trend validation.
Flip Conditions.
Valuation risk. a P/E above 55 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 67% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 1.44%.
Sanofi Consumer Healthcare India Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Sanofi Consumer Healthcare India Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Sanofi Consumer Healthcare India Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Sanofi Consumer Healthcare India Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Sanofi Consumer Healthcare India Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Sanofi Consumer Healthcare India Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Sanofi Consumer Healthcare India Limited stood at 94.6% of traded volume, against a 20-day average of 63.8%.
Sanofi Consumer Healthcare India announcements: results, concalls, ratings, M&A.
Filings Sanofi Consumer Healthcare India sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Sanofi Consumer Healthcare India files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 83 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Shareholders meeting
Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 26, 2026.…
Trading Window
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider…
Copy of Newspaper Publication
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of 3rd Annual General Meeting of the Company
Copy of Newspaper Publication
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication regarding the convening of the 3rd Annual…
Investor decks & rating reports.
Sanofi Consumer Healthcare India dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Sanofi Consumer Healthcare India has declared, sequenced by announce and record date.
Sanofi Consumer Healthcare India corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Sanofi Consumer Healthcare India insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Sanofi Consumer Healthcare India as reported to SEBI — buying and selling signals from the people who know the business best.
Sanofi Consumer Healthcare India insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Opal Bidco SAS | Insider | 11 Jun 2025 | buy | +25.05 L | ₹1,247.82 Cr. | ₹4,982.05 |
About Sanofi Consumer Healthcare India Limited: business, sector, key facts.
What Sanofi Consumer Healthcare India Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Sanofi Consumer Healthcare India Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: SANOFICONR, BSE: 544250.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited is a relatively new player in the Indian fast-moving consumer healthcare (FMCG) market, having been incorporated in 2023. The company focuses on providing over-the-counter (OTC) health solutions, specializing in three key areas: allergy relief, physical wellness, and pain management. Its operations are primarily within India, leveraging a multifaceted distribution network to reach consumers.
The company's product portfolio boasts a collection of established and recognizable brands catering to diverse health needs. These include Allegra for allergy relief, Combiflam for pain relief and fever reduction, Avil, another allergy medication, DePURA for digestive health, Festal for digestive enzyme support, and Novalgin NU, also for pain relief. This breadth of offerings allows them to target a wide range of consumer demographics and health concerns.
Sanofi Consumer Healthcare India's distribution strategy is comprehensive, utilizing a multi-channel approach to reach its target market. This network includes partnerships with distributors and wholesalers, direct sales to government institutions and hospitals, supply to pharmacies and pharmacy chains, and an expanding presence in the e-commerce sector. This diversified approach ensures widespread availability and accessibility of their products across various retail channels.
The company's organizational structure positions it as a subsidiary of Sanofi India Limited, benefiting from the resources and established presence of its parent company. This affiliation provides access to established research and development capabilities, marketing expertise, and a well-recognized brand name, offering a significant advantage in a competitive market. Based in Mumbai, the company leverages its strategic location to effectively manage its operations within India.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs and Pharmaceuticals (AKUMS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Sanofi Consumer Healthcare India Limited (SANOFICONR).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Sanofi Consumer Healthcare India Limited (SANOFICONR)?
The current share price of Sanofi Consumer Healthcare India Limited (SANOFICONR) is ₹4,707.2. Today, the stock has gained by ₹22.00 (0.47%), trading in a range of ₹4,652.1 to ₹4,789.3. The stock opened at ₹4,685.2 with a trading volume of 84,199 shares.
02Is Sanofi Consumer Healthcare India Limited stock a good investment for long-term?
Sanofi Consumer Healthcare India Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,847.42 crores, P/E ratio of 42.04, ROE of 71.60%, and ROCE of 89.90%. The dividend yield stands at 2.88%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Sanofi Consumer Healthcare India Limited stock?
The 52-week high price of Sanofi Consumer Healthcare India Limited (SANOFICONR) is ₹5,512, while the 52-week low is ₹3,975. Currently trading at ₹4,707.2, the stock is 47.6% away from its 52-week low and 14.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Sanofi Consumer Healthcare India Limited stock at the current price?
Whether to buy Sanofi Consumer Healthcare India Limited stock at ₹4,707.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 42.04 and P/B ratio of 28.24. Today's performance shows a gain of 0.47%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Sanofi Consumer Healthcare India Limited and when is the next dividend?
Sanofi Consumer Healthcare India Limited offers a dividend yield of 2.88%, which means for every ₹100 invested at the current price of ₹4,707.2, you can expect to receive approximately ₹2.88 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited's key financial metrics include: P/E Ratio: 42.04, P/B Ratio: 28.24, ROE: 71.60%, ROCE: 89.90%, Dividend Yield: 2.88%, EPS: ₹112.12, Book Value: ₹166.71, and Debt-to-Equity: 0.06. The company's market cap stands at ₹10,847.42 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Sanofi Consumer Healthcare India Limited stock performing today in the market?
Sanofi Consumer Healthcare India Limited stock opened at ₹4,685.2 and is currently trading at ₹4,707.2, showing a gain of ₹22.00 (0.47%). The intraday high is ₹4,789.3 and low is ₹4,652.1. The trading volume stands at 84,199 shares, indicating moderate market participation today.
08What is the P/E ratio of Sanofi Consumer Healthcare India Limited and what does it indicate?
Sanofi Consumer Healthcare India Limited has a Price-to-Earnings (P/E) ratio of 42.04, which means investors are willing to pay ₹42.04 for every ₹1 of earnings. With an EPS of ₹112.12, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Sanofi Consumer Healthcare India Limited (SANOFICONR) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.